May 22, 2013
Untitled Document
of 4209
Go to number
Investigation the effects of Citalopram on the level of change in the alpha and theta brain waves of patient with major depressive disorder referred to Farshchian hospital, Hamadan
Acronym :
IRCT registration number : Irct registration number : IRCT201203049202N1
Date registered : April 25, 2012
Registration timing : Registration while recruiting
   
Recruitment status : Recruitment complete
Expected recruitment start date : 2012-04-08
Expected recruitment end date : 2013-04-08
Funding source : Research Center For Behavioral Disorders And Substanses Abuse Of Hamedan University Of Medical Sciences
   
Scientific title : Investigation the effects of Citalopram on the level of change in the alpha and theta brain waves of patient with major depressive disorder referred to Farshchian hospital, Hamadan
Summary :

objective: this study would be done to investigate the effects of citalopram treatment on the level of change in the alpha and theta brain waves of patient with major depressive disorder referred to farshchian hospital, hamadan methods: 30 cases available random sampling of patients referred to the psychiatric ward after checking of the include and exclude criteria's on the basis of the criterion of the Diagnostic and Statistical Manual of mental disorders 4th edition will be selected. Inclusion criteria’s are only pure major depressive disorders that receive only citalopram and they don’t have any suicidal ideation. They are not post partum depression and they were not substance abuser in one year ago. Exclusion criteria’s are death, don’t like to continue and drug side effects.At first the scores of Hamilton depression scale plus scores in Quantitive ElectroEncephalography for all patients will be achieved. Then patients would be receiving for two months citalopram with a dose of 20-40 mg daily. Again they will response to Hamilton depression scales also their changes in level of alpha and theta will be record. Then the results of the pre and post test will be compared.

   
Public title : the effects of citalopram on brain waves of patients with major depressive disorder
Purpose : Treatment
Inclusion/exclusion criteria : inclusion criteria:the patient doesn’t have another psychiatric diseases;the patient doesn’t have any medical problem;the patient doesn’t have history of epilepsy; the patient doesn’t percept another antidepressant drugs;the patient isn't postpartum depression;the patient doesn’t have treatment with ECT in three months ago;the patient doesn’t have any material or psychiatric drugs abuse in 1 year ago;the patient doesn’t have suicidal idea exclusion criteria:if patient is dead;if patient has any side effect of the drug;if patient don't like to continue
Maximum age : 150
Gender : Both male and female
   
Health condition table is empty1 : major depressive dosorder
Condition studied : f30-f39
Condition ICD-10 code : Mood [affective] disorders
   
Intervention/Control1 citalopram 20- 40 mg oral once in day for 2 months
Intervention category Treatment: drugs
   
Primary outcome measure1: major depressive disorder
Primary outcome time point before intervention & 2 months after intervention
Primary outcome method of measurement hamilton depression rating scale
   
Secondary outcome measure 1 : response to treatment
Secondary outcome time point 2 months after intervention
Secondary outcome method of measurement hamilton depression rating scale
Trial phase : 4
Target sample size : 30
Randomization : N/A : single arm study
Blinding : Not blinded
Placebo : not used
Assignment : Single
Other design features :
   
Centre name 1 Psychiatric Clinic Of Hamadan Farshchian Hospital
Contact person's name Boshra Rahimi
Country Iran, Islamic Republic Of
Contact details : Farshchian Hospital, Honarestan Ave, Hamadan
hamadan
hamadan
65168-4-8741
00988118274191
00989183164516
00
b.rahimi@umsha.ac.ir/rahimi.boshra@gmail.com
   
Ethics committee name 1 Research Unit Of Hamadan University Of Medical Sciences
Date approved 2011-08-27
Reference number d-p-16-35-9-1730
Contact details : Hamadan University Of Medical Sciences, Shahid Fahmide Street, Hamedan
hamadan
hamadan
Iran, Islamic Republic Of
65178
   
Sponsor 1 Research Center For Behavioural Disorders And Substances Abuse Of Hamadan University Of Medical Scie
Contact person's name dr heidar tavilani
Contact details : Medical University, Opposite To Mardom Park, Shahid Fahmide Street, Hamadan
hamadan
hamadan
Iran, Islamic Republic Of
65178
00988118276295
00989183132210

tavilani@umsha.ac.ir
   
Person responsible for general inquiries
Boshra Rahimi
Affiliated Organization name Hamadan University Of Medical Sciences
Position/degree Resident of psychiatry
Contact details : Psychiatric group, Farshchian Hospital, Honarestan Ave, Hamadan
hamadan
hamadan
Iran, Islamic Republic Of
65168-4-8741
00988118274191
00989183164516
b.rahimi@umsha.ac.ir/rahimi.boshra@gmail.com
   
Person responsible for scientific inquiries
Mohammad Haghighi
Affiliated Organization name Hamadan University Of Medical Sciences
Position / degree Psychiatrist. Professor Assistant
Contact details : Psychiatric group, Farshchian Hospital, Honarestan Ave, Hamadan
hamadan
hamadan
Iran, Islamic Republic Of
65168-4-8741
00988118274191
00989133112905
haghighi@umsha.ac.ir/dr_haghighi-ps@yahoo.com
   
Person responsible for updating data
Boshra Rahimi
Affiliated Organization name Hamadan University Of Medical Sciences
Position / degree Resident of psychiatry
Contact details : Psychiatric group, Farshchian Hospital, Honarestan Ave, Hamadan
hamadan
hamadan
Iran, Islamic Republic Of
   
Registered by : Boshra  Rahimi
Hamedan University Of Medical Sciences
Hamedan University Of Medical Sciences
Hamedan
Hamedan
Iran, Islamic Republic Of
Phone: 00988118371533
Fax: 00988118253417
b.rahimi@umsha.ac.ir